Simplex Trading’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77 Hold
7
﹤0.01% 9114
2026
Q1
$108 Sell
7
-383
-98% -$8.45K ﹤0.01% 8871
2025
Q4
$9.25K Buy
390
+73
+23% +$2.15K ﹤0.01% 7033
2025
Q3
$9K Buy
+317
New +$9.99K ﹤0.01% 7990
2023
Q1
Sell
-49
Closed -$7K 10143
2022
Q4
$7K Sell
49
-6
-11% -$1.09K ﹤0.01% 7858
2022
Q3
$8K Sell
55
-167
-75% -$32.3K ﹤0.01% 8449
2022
Q2
$40K Sell
222
-16
-7% -$2.93K ﹤0.01% 6780
2022
Q1
$37K Buy
238
+167
+235% +$28.9K ﹤0.01% 7551
2021
Q4
$15K Sell
71
-20
-22% -$5.67K ﹤0.01% 8705
2021
Q3
$40K Hold
91
﹤0.01% 7800
2021
Q2
$40K Buy
+91
New +$45.4K ﹤0.01% 7929
2021
Q1
Sell
-1
Closed -$721 7551
2020
Q4
$61K Hold
1
﹤0.01% 5974
2020
Q3
$22K Hold
1
﹤0.01% 6307
2020
Q2
$31K Buy
+1
New +$229 ﹤0.01% 5899
2020
Q1
Hold
0
6982
2016
Q1
Hold
0
-$2K 6258
2015
Q4
Hold
0
4597

Other funds holding TRIB

Simplex Trading's TRIB Position: Q2 2026 in Review

Simplex Trading reduced its Trinity Biotech (TRIB) stake by 37% in Q2 2026, selling an estimated $130 and leaving 12 shares worth $137. The position accounts for ﹤0.01% of the portfolio, ranked #9081.

Simplex Trading first reported a position in TRIB in Q4 2014 and has held it in 19 quarters since. The position peaked at $28K in Q1 2021. 19 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.

  • Simplex Trading held 12 shares of Trinity Biotech worth $137 as of Q2 2026.
  • Simplex Trading sold 7 Trinity Biotech shares in Q2 2026, an estimated $130.
  • Trinity Biotech made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #9081 holding.
  • Simplex Trading first reported a position in Trinity Biotech in Q4 2014 and has held it in 19 quarters since.
  • Simplex Trading's Trinity Biotech position peaked at $28K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.